Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up – The SOLO study

Purpose: To evaluate the efficacy of intravitreal dexamethasone implants in eyes with cystoid macular oedema (CME) secondary to branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) in the clinical everyday practice, examine the effects of early retreatment and compare the results with the GENEVA study.

[1]  E. Stefánsson,et al.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. , 2001, Acta ophthalmologica Scandinavica.

[2]  P. Szurman,et al.  Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  H. Agostini,et al.  [Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs]. , 2010, Klinische Monatsblatter fur Augenheilkunde.

[4]  H. Ackermann,et al.  Combination therapy in diabetic macular oedema and retinal vein occlusion – past and present , 2012, Acta ophthalmologica.

[5]  S. Mennel,et al.  The vitreomacular interface in retinal vein occlusion , 2011, Acta ophthalmologica.

[6]  S. Mennel,et al.  Radial Optic Neurotomy for Central Retinal Vein Occlusion: Long-Term Retinal Perfusion Outcome , 2009, Ophthalmologica.

[7]  M. Blumenkranz,et al.  Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion , 2011, Clinical ophthalmology.

[8]  Sarah Gray,et al.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[9]  C. Meyer,et al.  RELEASE AND VELOCITY OF MICRONIZED DEXAMETHASONE IMPLANTS WITH AN INTRAVITREAL DRUG DELIVERY SYSTEM: Kinematic Analysis With a High-Speed Camera , 2012, Retina.

[10]  I. Scott,et al.  SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. , 2009, Ophthalmology.

[11]  P. Campochiaro,et al.  Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[12]  M. Parodi,et al.  Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting , 2012, Acta ophthalmologica.

[13]  Osamu Sawada,et al.  Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion , 2013, Acta ophthalmologica.

[14]  Ronald Klein,et al.  The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. , 2008, Archives of ophthalmology.

[15]  Ingrid U Scott,et al.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.

[16]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[17]  R. Ritch,et al.  Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis , 2010, Acta ophthalmologica.

[18]  G. Soubrane,et al.  Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes , 2009, Acta ophthalmologica.

[19]  S. Mennel,et al.  Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections , 2011, Acta ophthalmologica.

[20]  L. Hattenbach,et al.  Ophthalmologische Diagnostik und Bildgebung bei venösen retinalen Gefäßverschlüssen , 2011, Der Ophthalmologe.

[21]  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. , 1986, Archives of ophthalmology.

[22]  M. Maia,et al.  Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[23]  Tien Yin Wong,et al.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.

[24]  Monika Fleckenstein,et al.  Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high‐resolution, spectral‐domain optical coherence tomography , 2010, Acta ophthalmologica.